和铂医药-B11月18日斥资136.8万港元回购10万股

Core Viewpoint - The company, Heptagon Pharmaceuticals-B (02142), announced a share buyback plan, intending to repurchase 100,000 shares at a cost of HKD 1.368 million [1] Group 1 - The total amount allocated for the share buyback is HKD 1.368 million [1] - The company plans to repurchase a total of 100,000 shares [1] - The buyback is scheduled to take place on November 18, 2025 [1]